Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide.
Bull Exp Biol Med
; 162(2): 277-282, 2016 Dec.
Article
em En
| MEDLINE
| ID: mdl-27913938
Changes in the blood lipid spectrum and structural reorganization of the rat myocardium in response to injection of a single sublethal dose of doxorubicin (7 mg/kg) alone and in combination with course administration of betulonic acid amide (100 mg/kg/day for 14 days) were studied. Betulinic acid amide in the specified dose exhibited less pronounced cardiotoxic (necrobiotic impairment of cardiomyocytes) and dyslipidemic (increase of cholesterol and triglyceride levels) effects in comparison with doxorubicin. Combined treatment with betulinic acid amide and doxorubicin led to more pronounced remodeling of the myocardium, which was shown by a significant increase of the connective tissue/cardiomyocyte volume ratio detected by day 14 of the experiment.
Palavras-chave
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Triterpenos
/
Doxorrubicina
/
Dislipidemias
/
Cardiotoxicidade
/
Antibióticos Antineoplásicos
/
Antineoplásicos Fitogênicos
Tipo de estudo:
Etiology_studies
Limite:
Animals
Idioma:
En
Revista:
Bull Exp Biol Med
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Federação Russa
País de publicação:
Estados Unidos